Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What time is the CC tomorrow?
$EVARF: Exactly......... we can get to $0.50 this week
Once they figure out whats really going on here.
I'll add more here under $0.01......... if it gets there
GO $EVARF
Conference call this week on EVARF
$EVARF: Definitely still in............ DEFINITELY
Stents are in demand again.
GO $EVARF
EVARF conference call is next week. Anyone still in? It seems to be holding up above .01.
Anyone still holding EVARF? Holding up nicely above .01. Hopefully the coming conference call will boost it to the next level.
No worries with the spread this is the time to buy not sell
$EVARF
.5
Coming soon
$EVARF
$EVARF: AORFIX conference call next week
Remember.......... they paid $50Million for ALTURA !!!!!!!!!
https://www.linkedin.com/feed/update/urn:li:activity:6659412347137900544
GO $EVARF
added a KICK starter dudes... $EVARF
$EVARF: We'll be at $0.68 sooner than you know
I see this all as accumulation.
And building.
Low float helps as well as demand in the Lombard product offering.
Super cheap here at $0.03
GO $EVARF
EVARF moving higher again today.
EVARF looks good, just needs some more people to discover it.
$EVARF: Its the STENT.... its all over the news
Thats the IP here.
People only just starting to realize that coronary issues are popping up with CoronaVirus cases.
EVARF has the solution.
GO $EVARF
EVARF moves on air. If we get any real buying, it could really fly.
$EVARF: You just saw DECN go $0.03 to 0.45
Don't think this doesn't have potential.
It has TONNES of upside here.
Especially in this day and age.
LOMBARD has the tech........... and Altura purchase was sweet.
GO $EVARF
$EVARF: Do you realize how quickly we can get to $3
Just look at all these cases involving Stroke & Heart issues with CoronaVirus.
Lombard has a better STENT
Crazy cheap here at $0.02
GO $EVARF
$EVARF: Stents in focus............ because of CoronaVirus cases
https://www.washingtonpost.com/health/new-cdc-data-on-underlying-health-conditions-in-coronavirus-patients-who-need-hospitalization-intensive-care/2020/03/31/0217f8d2-7375-11ea-85cb-8670579b863d_story.html
GO $EVARF !!!!!!!!
EVARF getting some action today. All trades at the ask, unfortunately the spread is still huge.
Maybe they didn’t acquire the ticker along with the business
I just read on their sight that they were acquired back in 2018
They look to be doing well... idk...It’s a lot of work to keep up with the SEC maybe they just let it go for a while and they’re gonna plan on putting some effort towards it soon
I've been to their websight but why let it go delisted due to lack of reporting? If they would just address that one issue the stock could do nicely
https://www.lombardmedical.com/ weird cause website up to date and Twitter
just did some digging..... seems as though this thing was delisted in 2017...…...Why would a 20 year old company let theier stock get selisted?
GL...someone trying to hold it back... there wasn't much at 5 so maybe it's time to leave this range for a while
Not yet..... It spiked on me and if I have to wait forever on this stock I want to be in at a good price
Thanks for the paint down 6 into my glove:)
Nice.... this looks like it could be a real Ball Z mover
Yea my team grabbed .005-.006 too
I tapped 5 and hell broke loose!! $EVARF
$EVARF: Penny breakage....... rolling time
Rollllllllllllinggggggggggggggg
Gonna go nice and hard
GO $EVARF
$EVARF: Its hardly even looked at.......
But when it matters, you'll see.
The tech is good.
The solution is proven.
GO $EVARF
I'm thinking of throwing 1k into this and just closing my eyes...…. Do you know if they have any toxic debt, do you have clowns showing up on the board yelling scam, fraud, the sky is falling?
Have they ever issued any financials?
$EVARF: Aorfix is being used..........
https://www.lombardmedical.com/clinicians/aorfix
No mystery here.
Just not getting the attention it deserves.
It will though.
Did you hear about Jamie Dimons emergency heart surgery yesterday ?
GO $EVARF
What is the story behind this stock? Anyone have any info or forecasts?
$EVARF: Buying this juicy dip here at $0.02
Nice for it come down one more time.
Looking for a nice bounce in due time.
GO $EVARF
$EVARF: Funny thing is.... they paid $50Million for Altura
Lombard Medical is extremely undervalued at this price.
This will surely go over $0.25 and all it will take is a News Release
like $ALRT had recently which saw it spike from $0.01 to $0.25/sh
Mark this post... I've seen it happen before and it will happen again.
I'm loaded up here down in the $0.03/sh level and will most likely
be adding more.
Others will catch on later.
http://www.lombardmedical.com/pwpcontrol.php?pwpID=18284
****************************************************************
Making a dent in the stent market: Altura Medical acquired by Lombard Medical for $50.5M
By MEGHANA KESHAVAN
Jul 30, 2015 at 5:32 PM
Silicon Valley-based Altura Medical, the venture-backed maker of an endovascular aneurysm repair device, just got acquired by the publicly traded Lombard Medical for $50.5 million.
Altura Medical’s platform actually fits quite well with Lombard’s Aorfix device, which develops devices for endovascular repair as well.
Such aortic stent grafts have been called out as growth markets for venture capitalists, as seen in a 2009 academic paper from Seminars of Interventional Radiology:
Endovascular devices for the treatment of abdominal and thoracic aortic disease are poised to become the next $1 billion medical device market. A shift from open repair to endovascular repair, advances in technology, screening initiatives, and new indications are driving this growth.
This acquisition is notable in context of the paper, however, because:
Although billion-dollar medical device markets are rare, this field is fraught with risk and uncertainty for startups and their venture capital investors. Technological hurdles, daunting clinical and regulatory timelines, market adoption issues, and entrenched competitors pose significant barriers to successful new venture creation. In fact, the number of aortic endografts that have failed to reach commercialization or have been pulled from the market exceeds the number of Food and Drug Administration–approved endografts in the United States.
So it’s particularly notable that Altura’s endograft device received a CE mark this year, and Lombard plans to roll it out in Europe this upcoming January, the companies said in a statement. It’ll apply for an IDE from the U.S. Food and Drug Administration early next year, and plans to kick off a clinical trial later in 2016.
Altura was bought out with $15 million in Lombard common stock at $4 per share, and will assume $5.5 million of the startup’s bank debt and $2.5 million in liabilities.
The Altura device offers a way to graft to the renal artery in a less invasive manner that’s meant to be simpler and more intuitive.
Q..
Do you know why a OTCQX stock super cheap @ this PPS?
What was the cause of it?
Thanks!
$EVARF: Hitting $0.11... Going back to $0.20/sh
Have a great day.
Nice juicy bouncer on watch now.
$EVARF
$EVARF: Watching for a break past $0.10/sh now
Lets see the bounce transpire.
Its completely broken down.... Business intact.
Should retest and reacquire $0.35/sh level again.
Lombard MEDICAL
$EVARF
$EVARF: Got some $0.035... Looks good to BOUNCE here
Super beaten down chart.
Volume rolling in now.
Watching this for a bounce to $0.10/sh
http://www.lombardmedical.com/
GO $EVARF
EVAR changed to EVARF and delisted from the Nasdaq to the OTC:
http://otce.finra.org/DLAdditions
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
339
|
Created
|
11/26/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |